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ABSTRACT
The main goals of the therapy of simple bone cyst (SBC) are to get the bone healing, prevent pathological fractures, and 
management of pain symptom. There are various methods of the SBC treatments, however they still remain controversial 
because of their healing rate and invasiveness of surgery. 
A total of 10 SBC patients were divided into two groups namely curretage with hydroxyapatite (HA) and  decompression 
and percutaneous steroid injection (PSI). PSI was performed three times at intervals of each month. The mean follow-
up of 12-26 months. Evaluation of functional outcome by Musculoskeletal Tumour Society (MSTS) score and supported 
with radiologically based on Chang criteria.
There were 5 patients (proximal femur 2; proximal humerus 2, radius 1)  performed curretage with HA therapy. 
Remaining 5 patients (proximal femur 3; proximal humerus 1; calcaneus 1) were performed PSI therapy. PSI group had 
better MSTS score, particulary at month 3 (55%) and  month 6 (84%)  than curettage with HA therapy (47% and 69.3%). 
Complete bone healing was found in both group at month 12 follow up, however solid union occurred faster in PSI group.
PSI tends to have faster and better functional outcome than curettage and HA. Curettage with HA and PSI have similar 
complete bone healing at month 12 follow up. 
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ABSTRAK
Target utama penalaksanaan simple bone cyst (SBC) adalah mencapat penyembuhan tulang yang sempurna, mencegah 
fraktur patologis dan mengatasi gejala nyeri. Ada beberapa metode penatalaksanaan SBC, namun demikian masih 
menjadi perdebatan dikarenakan perbedaan angka penyembuhannya dan jenis pembedahan yang invsif.
Sepuluh pasien yang didiagnosis SBC dikelompokkan menjadi kelompok yang mendapat tindakan curretage dan 
pengisian defek dengan  hydroxyapatite (HA) dan kelompok dekompresi dan percutaneous steroid injection (PSI). 
Prosedur PSIdilakukan sebanyak 3x dengan interval waktu satu bulan. Follow up dilakukan selama 12 – 26 bulan. 
Evaluasi luaran fungsional menggunakan Musculoskeletal Tumour Society (MSTS) score dan secara radiologi sesuai 
criteria Chang.
Terdapat 5 pasien (2 femur proksimal, 2 humerus proksimal, dan 1 radius) yang dilakukan prosedur curretage dan 
pengisian defek dengan  HA. Lima pasien sisanya ( 3 fenur proximal, 1 humerus  proximal dan 1 calcaneus) dilakukan 
prosedur PSI. Luaran fungsional Kelompok PSI memiliki MSTS score yang lebih baik, khususnya pada bulan ke- 3 (55%) 
dan bulan ke-6 (84%) daripada kelompok  curettage dengan HA  (47% dan 69.3%). Penyembulan tulang sempurna 
menunjukkan hasil yang sama pada evaluasi bulan ke-12, tetapi solid union didapatkan lebih cepat pada kelompok PSI.
Kelompok PSI memiliki kecenderungan solid union dan luaran fungsional yang lebih cepat daripada kelompok 
curettage dengan HA.  Kedua kelompok mencapai penyembuhan sempurna pada bulan ke-12 follow up.  
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INTRODUCTION
The simple bone cyst (SBC) is a benign fluid-filled lesion which is located mainly in the metaphysis 
of the long bones, seen in patients before skeletal 
maturity.1-4 It is the most common benign lytic lesion 
and mainly occurs in the first two decades of life with 
boy and girl ratio 2:1.5 Sometimes, SBC is classified 
as a tumor-like lesion. The cavity of the cyst usually 
contains clear yellowish sero-sanguinous fluid.1-3 
The radiological appearance of SBCs is characteristic.4 
On radiograph, the SBC demonstrates a well-localized 
lytic lesion with sclerotic margins in the medullary 
canal without periosteal reaction. However, periosteal 
reaction may be seen at the fracture-healing stage 
when the SBC has a pathological fracture. The cyst 
may expand concentrically but never penetrates bone 
cortex. 1-4 
Uncomplicated SBCs are painless and are 
diagnosed when a pathological fracture takes place 
or we incidentally find on a radiograph. 4 However, 
the cysts close to the growth plate show biological 
activity recur more often than those which move 
away from the growth plate. An active cyst near the 
physics may cause retardation of longitudinal growth 
in up to 14% of patients.4 Fortunately, they might 
heal spontaneously in adulthood.3 The treatment is 
indicated in pain, pathological fracture, or risk of a 
fracture.1-3, 6
The main goal of SBC therapy is to obtain complete 
bone healing, prevent pathological fractures and 
symptom management (pain or fracture). There are 
several alternative treatments for SBC such are 
curettage combined with bone graft or synthetic 
graft such as hydroxyapatite (HA), calcium phosphate 
or calcium sulfate, decompression combined with 
percutaneous steroid injection (PSI), aspiration and 
injection of autologous bone marrow, and continuous 
decompression with flexible intramedullary nail and 
cannulated screw.7,8
Intralesional curettage combined with bone graft 
or synthetic graft is the most common procedure 
for SBC treatment.9,10 It is also to be a standard 
treatment in all SBC patients in our hospital before 
2013. Curettage eradicates the source of enzymes 
that destroy bone by cleaning the cyst membrane 
and bone/synthetic graft acts as an osteoconductive 
for bone healing process. HA is often used to fill 
bone defects and effectively used in the SBC. 6,7
PSI was initially stated to give favorable results 
in 90% of cases with no growth arrest or secondary 
deformity, but Campanacci et al (1986) reported a 
15% recurrence rate, with only 50% of cysts showing 
complete healing.4 The low morbidity and simplicity 
of steroid injection made it popular and as treatment 
option instead of curettage combined with bone 
graft or synthetic graft. In our hospital, decompression 
and PSI has been a treatment option since 2013. 
We have investigated the functional outcomes of 
SBCs treated by curettage combined with HA and 
PSI. It is expected to be applied in the management 
for SBC patients and provide clinical decision making.
MATERIAL AND METHODS
This study is a retrospective cohort of SBC patients 
who underwent curettage combined with HA or PSI. 
The lesions had a typical radiographic appearance 
diagnosed without needle or open biopsy before 
the definitive treatment. 
We conducted PSI three times with a month 
period between an injection to another one. PSI was 
also performed in one case of SBC with pathological 
fracture which applied after the occurrence of fracture 
healing. The PSI in our hospital was performed with 
the following procedure:
1. With the patient under general anesthesia, we 
visualize the lesion with C-arm guidance.
2. Core bone needles no 11 are introduced in the 
proximal and the distal pole of the cystic lesion.
3. We evaluate the fluid (color) which came out 
from the cavity without force and send it to 
histopathologic examination.
4. After the characteristic fluid of SBC is empty, 
we aspirate haemoraghic one from the cavity 
and also send it to histopathologic examination.
5. The cavity was flushed with normal saline from 
proximal core bone needle. 
6. With closed distal core bone needle, we perform 
PSI 80–120 mg. 
7. Functional outcome using musculoskeletal tumor 
society (MSTS) score was evaluated on month 
1, 3, 6, and 12 after surgery. 
Statistical analysis was conducted using SPS and 
a p value of < 0.05 was considered significant.
RESULTS 
Of the 10 patients, 5 had curettage and HA and 
others received PSI as their treatment The mean 
age of the patients was 13.0 ± 5.8 years with the 
highest incidence in the second decade 6 of 10 
patients were male. Five of 10 lesions were located 
in the proximal femur and 3 of 10 patients had 
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lesions in the proximal humerus. Other lesions 
recorded was in radius and calcaneous bone (1 case 
each). Seven of 10 lesions were located in metaphyses 
and left-sided (6 of 10). Four patients presented 
with pathologic fractures. We followed up 19.6 ± 
8.4 months for each patient. The curettage group 
had significantly longer follow-up time (p = 0.008) 
compared to PSI group. The overall characteristic 
features of this study are shown in table 1.
Table 1: Demographic and clinical characteristic SBC patient 
Treatment options
p-value*PSI Curettage + HA 
N1=5 N2=5 
Age, years–mean(SD) 11.6 ± 5.2 14.4 ±6.7  
Age Group, years  
 0–10 2 2 
11–20 3 2 
21–30 0 1 
Sex  
Male 4 (80) 2 (40) 
Female 1 (20) 3 (60) 
Time of follow-up months 
(SD) 
12,6 (5,55) 26,6 (2,07) 0.008 
Tumor Location >0.999 
Proximal femur 3 (60) 2 (40) 
Proximal humerus 1 (20) 2 (40) 
Radius 0 (0) 1 (20) 
Calcaneus 1 (20) 0 (0) 
Tumor Location  
Metaphyseal 4 (80) 3 (60) 
Diaphyseal 1 (20) 2 (40) 
Pathological Fracture 
Yes 1 (20) 3 (60) 
No 4 (80) 2 (40) 
*P-value is analyzed using exact Fisher Test for proportional data, and 
parametric independent-T Test for numerical data 
Both groups showed improvement of MSTS score 
from month to month. MSTS score was higher in 
the PSI group than in curettage group and showed 
statistically significant difference at month 3 (p = 
0.032) and month 6 (p = 0.008) after surgery. (Table 2).
Table 2: Functional outcome of SBC patient on the 1st month, 3rd 




MSTS score, median 
Month 1  9.0 ( 7.8–10.0 )  9.0 (7.5–10.5)  9.0 (7.5–9.5) 0.548
Month 3 15.0 (13.8–16.3) 16.0 (15.0–18.0) 14.0 (13.0–15.0) 0.032
Month 6 22.5 (20.8–26.0) 26.0 (23.5–26.5) 21.0 (19.5–22.0) 0.008
Month 12 28.0 (29.5–30.0) 28.0 (30.0–30.0) 26.5 (29.0–30.0) 0.690
*P-value is analyzed using exact Fisher Test for proportional data, and Mann-
Whitney U for numerical data
DISCUSSION 
SBC or unicameral bone cyst also known as 
solitary bone cyst is a benign unilocular tumor or 
partially septed fluid-filled cyst. The combination 
of substance inside the fluid containing prostaglandins, 
free oxygen radical, interleukins, cytokines and 
metalloproteinases as well as the pressure of the 
fluid inside the cyst which is higher compared to 
pressure on the bone marrow result in bone necrosis. 
Although some SBCs will spontaneously recover, 
the other lesions may enlarge until causing symptoms 
that require treatment.8,10,11
Male and female ratio patient is 1.5 : 1 with a peak 
incidence in the second decade of age (5 of 10) followed 
by the first decade (4 of 10) and the third decade (1 
of 10). Yandow reported that the male to female ratio 
is 3 : 1 and Dorman stated male to female ratio is 1 : 
1.8 In previous studies, the relationship between basic 
characteristics with bone healing and SBC recurrence 
remains controversial. Those confirm that there is a 
significant relationship between the size of the cyst and 
the patient’s age but not on gender, location and type 
of cyst, and pathologic fracture.12,13
PSI has been used for long in SBC and still a 
recommendation on SBC treatment. It was firstly 
performed by Scaglietti et al. In 1979, which reported 
a high rate of bone healing after injection.14,15 The role 
of methylprednisolone in enhancing bone healing 
is by reducing the cyst fluid production from the 
inner cyst wall with its anti-prostaglandin effect or 
by decreasing the cyst pressure after initially drilling 
a hole and aspirating the fluid.14,16-18 In other hand, 
SBCs were initially treated with curettage and bone 
grafting, but the recurrence rate was 40-60%. Curettage 
may eradicate the source of osteolytic enzymes by 
ridding the cyst membranes. Either autograft or 
allograft or HA may be used to fill the cavity. HA 
as a bone graft substitute also serves as an 
osteoconductive for bone healing process.18,19
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Figure 1: Intra-operative therapy with: A. PSI and B. Curettage with HA
In the PSI group, 3 of 5 subjects had SBC in the 
proximal femur, 1 in proximal humerus and 1 in 
calcaneus. All subjects in this group showed a 
complete bone healing. Complete bone consolidation 
was evaluated radiographically (figure 2).12,13 This 
result was similar to study conducted by A. Hashemi-
Nejad and Cole.13 However, they concluded that the 
healing response of PSI is unpredictable and usually 
incomplete even after the repeated injections. Some 
studies reported that PSI highly reduced the amount 
of the cyst volume.12,20,21
Figure 2: Hip X-Ray of PSI therapy in SBC patient: A. Before surgery, B. 
Month 6 after surgery, C. Month 12 after surgery. 
Three of 5 patients in curettage combined with 
HA came to us with pathological fracture. After 
having curettage and HA, the fracture was stabilized 
with internal fixation. All cases in this group with 
or without pathologic fracture demonstrated complete 
bone healing (figure 3). This result was supported 
by previous study which showed 100% complete 
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Figure 3: Hip and Femur X-Ray of Curettage therapy in SBC patient: A. 
Before surgery; B. Month 1 after surgery; C. Month 6 after surgery; D. 
Months 12 after surgery.
Several predictive factors for therapy such as 
age, cyst size, sex, location of the cyst, and the type 
(active/latent), the presence of pathological fracture 
has been investigated. Hashemi-Nejad and Cole 
said that there was no significant relationship 
between radiological result and cyst size, type of 
cyst or age of the patient. 20 Chang et al., reported 
significant relationship between the size of the cyst 
and the patient’s age, but not on gender, location, 
type of cyst, and pathologic fracture.21 A meta-
analysis of SBC therapy showed that the curettage 
therapy had higher bone healing (98.7%) compared 
to steroid therapy (77.4%).17 While, some studies 
recommended steroid therapy as a method of choice 
because it was easier, effective, and safe.12,20
The functional outcome MSTS is into upper and 
lower extremity with a maximum score of 30. In 
this study the total amount presented in the form 
of a percentage was divided into four categories, 
namely: poor if < 25%, fair when 25–49%, good 
50–75% and excellent > 75–100%. The MSTS score 
on PSI group was higher than curettage group. All 
patients treated by PSI could walk without supported 
aids at month 4 after surgery. In contrast, the 
patients treated by curettage and HA walked full 
weight bearing at month 12. From the small number 
of those cases, it may be concluded that PSI therapy 
has outcome than the curettage and HA therapy. It 
was radiologically supported with complete solid 
union. PSI group tended faster solid union than 
curettage group. Fortunately, at month 12 after 
surgery both groups demonstrated the excellent 
functional outcome and complete bone healing 
(Table 2).
CONCLUSIONS
As a conclusion, PSI tended to faster and had 
similar functional outcome than curettage and HA. 
Considering the simplicity of procedure, low cost, 
and high availability, PSI can be used as a choice 
of treatment for patients with SBC. However, further 
studies with larger sample are needed.
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Figure 2: Hip X-Ray of PSI therapy in SBC patient: A. Before surgery, B. 
Month 6 after surgery, C. Month 12 after surgery. 
Three of 5 patients in curettage combined with 
HA came to us with pathological fracture. After 
having curettage and HA, the fracture was stabilized 
with internal fixation. All cases in this group with 
or without pathologic fracture demonstrated complete 
bone healing (figure 3). This result was supported 
by previous study which showed 100% complete 
healing with this treatment.20
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